NCT03016091 2025-02-18A Trial of Pembrolizumab for Refractory Atypical and Anaplastic MeningiomaRabin Medical CenterPhase 2 Terminated18 enrolled 9 charts
NCT01117844 2024-11-07Proton Radiation For Meningiomas and HemangiopericytomasAbramson Cancer Center at Penn MedicinePhase 1/2 Completed53 enrolled